Biotech by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 biotech ranked by P/B ratio, at 1.9, followed by Vaxcyte (3.5) and Neurocrine Biosciences (4.2). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen1.9
Median
9.0
Combined market value
SGD 1.08T
Countries
5
Not ranked
6no P/B ratio on file

Market values as of .

Biotech by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care1.9SGD 47.5BSGD 321.62 0.57% down 49% up United States
2VaxcytePCVX · Health Care3.5SGD 12BSGD 75.97 0.83% down 22% up United States
3Neurocrine BiosciencesNBIX · Health Care4.2SGD 21.2BSGD 209.39 2.15% down 20% up United States
4RepligenRGEN · Health Care4.6SGD 14.1BSGD 219.84 5.10% up 5% up United States
5Bio-TechneTECH · Health Care5.3SGD 14.7BSGD 93.80 0.13% up 26% up United States
6Kymera TherapeuticsKYMR · Health Care6.4SGD 13.3BSGD 155.39 0.86% down 87% up United States
7Krystal BiotechKRYS · Health Care6.4SGD 11.8BSGD 397.97 3.35% up 46% up United States
8CG OncologyCGON · Health Care7.2SGD 9.2BSGD 102.60 0.77% up 85% up United States
9Twist BioscienceTWST · Health Care8.8SGD 10.1BSGD 148.32 2.68% up 340% up United States
10ExelixisEXEL · Health Care9.2SGD 21.7BSGD 88.84 0.55% up 63% up United States
11ImmunovantIMVT · Health Care10.6SGD 9BSGD 43.37 1.26% up 43% up United States
12ModernaMRNA · Health Care11.9SGD 104.8BSGD 259.01 2.89% down 755% up United States
13Revolution MedicinesRVMD · Health Care14.4SGD 44.6BSGD 206.21 1.72% down 131% up United States
14Gilead SciencesGILD · Health Care16.0SGD 269.6BSGD 217.40 1.00% down 33% up United States
15AmgenAMGN · Health Care16.8SGD 311.9BSGD 576.57 2.38% down 34% up United States
16Adaptive BiotechnologiesADPT · Health Care25.8SGD 5.9BSGD 36.25 1.33% down 88% up United States
17Scholar Rock HoldingSRRK · Health Care34.2SGD 7.4BSGD 61.04 4.99% up 14% up United States
18Kodiak SciencesKOD · Health Care490SGD 8.1BSGD 123.94 0.72% down 396% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2897 SGD). 6 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/B ratio?

Biogen (1.9), Vaxcyte (3.5) and Neurocrine Biosciences (4.2) have the lowest P/B ratio of the 18 biotech ranked here as of 18 Nov 2026, 16:15 UTC.

How many biotech are in this ranking?

18 are ranked by P/B ratio. 6 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 18 biotech ranked by P/B ratio have a combined market value of SGD 1.08T as of 18 Nov 2026, 16:15 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech by P/B ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.